Refresh

GLENMARK PHARMACEUTICALS LTD. - Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets USP, 60 mg


Download
23 Mar 2016
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated March 23, 2016, titled "Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets USP, 60 mg".<BR>

Source: BSE India

View all announcements for GLENMARK PHARMACEUTICALS LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com